PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors

• Asıl Yazarlar: C. Garufi (Yazar), S. Mancuso (Yazar), F. Ceccarelli (Yazar), L. Caruso (Yazar), C. Alessandri (Yazar), M. Di Franco (Yazar), R. Priori (Yazar), V. Riccieri (Yazar), R. Scrivo (Yazar), S. Truglia (Yazar), F. Conti (Yazar), F.R. Spinelli (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: PAGEPress Publications, 2024-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Objective. Patients Acceptable Symptom State (PASS) is a single dichotomized question assessing health satisfaction. We aimed to investigate PASS achievement within 4 weeks of treatment with Janus kinase (JAK) inhibitors (Jakinibs) and its association with treatment response after 4 and 12 weeks in...